| Business Summary | | Possis
Medical,
Inc.
is
a
developer,
manufacturer
and
marketer
of
medical
devices.
The
Company's
products
include
the
AngioJet
Rheolytic
Thrombectomy
System,
the
Perma-Seal
Graft,
the
Perma-Flow
Coronary
Bypass
Graft,
and
the
ePTFE
Synthetic
Vascular
Graft.
The
Company
is
currently
focused
in
the
further
development
and
marketing
of
the
AngioJet
system.
The
Company
markets
this
system
to
interventional
cardiologists,
interventional
radiologists,
vascular
surgeons,
and
also
to
physician
specialty
groups,
including
vascular,
cardiovascular
and
thoracic
surgeons
in
the
United
States
and
in
other
countries. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Possis
Medical,
Inc.
is
a
developer,
manufacturer
and
marketer
of
medical
devices,
operating
in
one
business
segment.
For
the
nine
months
ended
4/30/01,
revenues
rose
48%
to
$20.8
million.
Net
loss
fell
50%
to
$3.9
million.
Revenues
reflect
the
clearances
to
commence
U.S.
marketing
of
the
AngioJet
System.
Lower
loss
also
reflects
the
cost
savings
related
to
the
work
force
reduction
and
a
reduction
in
sales
product
demonstrations
and
samples. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Donald Wegmiller, 62 Chairman | -- | -- | Robert Dutcher, 55 Pres,
CEO | $251K | $86K | Eapen Chacko, 52 CFO,
VP-Fin. | -- | -- | Irving Colacci, 47 VP,
Legal Affairs and HR, Gen. Counsel and Sec. | 146K | 30K | James Gustafson, 44 VP,
Quality Systems and Regulatory/Clinical Affairs | 140K | -- | Dollar amounts are as of 31-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|